How many insider declarations has Utchanah, Arvind filed?

Utchanah, Arvind has filed 4 public insider declarations with SEDI.

What is Utchanah, Arvind's role?

Utchanah, Arvind's reported role is not specified by the regulator across the filings.

Which companies does Utchanah, Arvind report trades for?

Utchanah, Arvind reports trades for Knight Therapeutics Inc..

What is Utchanah, Arvind's declared buy vs sell volume?

Across the available history, declared buys total 5k€ and disposals 0.

← Executives ★ Sign in to follow

UA

Utchanah, Arvind

OFFICER

·SEDI

Knight Therapeutics Inc.

累计流向

0

申报总数

0

公司

€4,966

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by Utchanah, Arvind. Officer active across 1 company, notably Knight Therapeutics Inc.. In total, 4 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 June 2026. The latest transaction was filed on 13 July 2026 (51 - Exercise of options). Regulator: SEDI. All data is openly available.

Companies and markets linked to Utchanah, Arvind

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Knight Therapeutics Inc. (CA)

申报4 总计

◇

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年7月13日Knight Therapeutics Inc.

CA$62,5120SEDI ↗

8,066 股@ CA$7.75Common SharesTSXSEDI:4752576

◇

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年7月13日Knight Therapeutics Inc.

CA$349,1690SEDI ↗

45,054 股@ CA$7.75OptionsTSXSEDI:4752573

▲

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$1,54542SEDI ↗

296 股@ CA$5.220.0001% mcap19.2% 占其流量Common SharesTSXSEDI:4736905

标准退出：2026年9月13日 (T+90)

▲

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$6,50548SEDI ↗

695 股@ CA$9.360.0004% mcap80.8% 占其流量Common SharesTSXSEDI:4736904

标准退出：2026年9月13日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

UA

Utchanah, Arvind

OFFICER

·SEDI

Knight Therapeutics Inc.

累计流向

0

申报总数

0

公司

€4,966

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by Utchanah, Arvind. Officer active across 1 company, notably Knight Therapeutics Inc.. In total, 4 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 June 2026. The latest transaction was filed on 13 July 2026 (51 - Exercise of options). Regulator: SEDI. All data is openly available.

Companies and markets linked to Utchanah, Arvind

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Knight Therapeutics Inc. (CA)

申报4 总计

◇

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年7月13日Knight Therapeutics Inc.

CA$62,5120SEDI ↗

8,066 股@ CA$7.75Common SharesTSXSEDI:4752576

◇

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年7月13日Knight Therapeutics Inc.

CA$349,1690SEDI ↗

45,054 股@ CA$7.75OptionsTSXSEDI:4752573

▲

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$1,54542SEDI ↗

296 股@ CA$5.220.0001% mcap19.2% 占其流量Common SharesTSXSEDI:4736905

标准退出：2026年9月13日 (T+90)

▲

Utchanah, Arvind

5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$6,50548SEDI ↗

695 股@ CA$9.360.0004% mcap80.8% 占其流量Common SharesTSXSEDI:4736904

标准退出：2026年9月13日 (T+90)

4 条申报中的 4 条

Utchanah, Arvind

内部人交易记录

Companies and markets linked to Utchanah, Arvind

Related entities

Utchanah, Arvind

内部人交易记录

Companies and markets linked to Utchanah, Arvind

Related entities